Fragile X–related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study
Author(s) -
Yoshimi Inaba,
Amy S. Herlihy,
Charles E. Schwartz,
Cindy Skinner,
Minh Bui,
Joanna Cobb,
E. Shi,
David Francis,
Alison Arvaj,
David J. Amor,
Kate Pope,
Tiffany Wotton,
Jonathan Cohen,
Jacqueline Hewitt,
Randi J. Hagerman,
Sylvia A. Metcalfe,
John L. Hopper,
Danuta Z. Loesch,
Howard R. Slater,
David E. Godler
Publication year - 2012
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2012.134
Subject(s) - testis determining factor , klinefelter syndrome , aneuploidy , x chromosome , genetics , epigenetics , biology , karyotype , fragile x syndrome , dna methylation , chromosome , y chromosome , endocrinology , gene , gene expression
We show that a novel fragile X-related epigenetic element 2 FMR1 methylation test can be used along with a test for sex-determining region Y (SRY) to provide the option of combined fragile X syndrome and sex chromosome aneuploidy newborn screening.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom